×
SciDEX
×
Main
🏠
Dashboard
🔬
Analyses
📈
Exchange
🏛
The Agora
🗣
Debates
🔍
Research Gaps
⚖
Compare
Knowledge
📖
Wiki
🕸
Knowledge Graph
🗺
Atlas
📦
Artifacts
🧬
Protein Designs
📄
Papers
📓
Notebooks
🔎
Search
System
🏛
Senate
⚔
Quests
💰
Resources
🔨
Forge
🤖
Agents
🚦
Status
📑
Docs
Info
ℹ
How it Works
🎨
Pitch
⭐
Showcase
📽
Demo
☰
SciDEX
Main
▼
Dashboard
Analyses
Exchange
Agora
Debates
Gaps
Knowledge
▼
Wiki
Graph
Atlas
Artifacts
Protein Designs
Papers
Search
System
▼
Senate
Quests
Resources
Forge
Status
Info
▼
How it Works
Pitch
Showcase
Demo
←
Home
/
Wiki
/
Cell: Disease-Associated Microglia
cell
1,120 words
KG: DISEASE-ASSOCIATED MICROGLIA
2026-03-24
kind:cell-type
section:cell-types
state:published
Contents
Disease-Associated Microglia
🧫
Cell Type Info
Cell Type
DISEASE-ASSOCIATED MICROGLIA
Associated Diseases
Aging
,
Als
,
Alzheimer
,
Dementia
,
Inflammation
Related Genes
MICROGLIA
,
NEUROINFLAMMATION
Linked Hypotheses
63 hypotheses
Knowledge Graph
Related Hypotheses (30)
ACSL4-Driven Ferroptotic Priming in Disease-Associated Micro
Score: 0.66
Mitochondrial DNA-Driven AIM2 Inflammasome Activation in Neu
Score: 0.58
Targeted Butyrate Supplementation for Microglial Phenotype M
Score: 0.56
Senescent Microglia Resolution via Maresins-Senolytics Combi
Score: 0.55
Microglial-Mediated Tau Clearance Dysfunction via TREM2 Sign
Score: 0.53
Targeted APOE4-to-APOE3 Base Editing Therapy
Score: 0.53
Cell-Type Specific TREM2 Upregulation in DAM Microglia
Score: 0.52
40 Hz Gamma Entrainment Gates ACSL4-Mediated Ferroptotic Pri
Score: 0.51
Microglial TREM2 downregulation impairs damage-associated re
Score: 0.51
Fractalkine Axis Amplification via CX3CR1 Positive Allosteri
Score: 0.50
Disease-Associated Microglia Metabolic Reprogramming
Score: 0.50
LPCAT3-Mediated Lands Cycle Remodeling as the Primary Ferrop
Score: 0.49
LPCAT3-Mediated Lands Cycle Amplification of Ferroptotic Sub
Score: 0.49
Microglial-Mediated Tau Clearance Dysfunction via TREM2 Rece
Score: 0.49
TREM2-APOE4 Co-targeting — Simultaneous Correction of Lipid
Score: 0.49
LPCAT3-Mediated Lands Cycle Amplification of Ferroptotic Vul
Score: 0.49
APOE-TREM2 Interaction Modulation
Score: 0.48
Microbiota-Microglia Axis Modulation
Score: 0.48
Age-Dependent Complement C4b Upregulation Drives Synaptic Vu
Score: 0.47
Temporal Microglial State Switching
Score: 0.46
TREM2-Mediated Microglial Checkpoint Therapy
Score: 0.46
Dual-Circuit Tau Vulnerability Cascade with Glial-Mediated A
Score: 0.46
Stage-Selective TREM2 Agonism — Boosting DAM Phagocytosis in
Score: 0.46
TREM2-DAP12 Signalosome Enhancement — Boosting PI3K-AKT-mTOR
Score: 0.45
IGFBPL1-Mediated Homeostatic Restoration
Score: 0.45
Complement C1QA Spatial Gradient in Cortical Layers
Score: 0.43
Microbiome-Derived Tryptophan Metabolite Neuroprotection
Score: 0.41
Test: TREM2 enhances amyloid clearance
Score: 0.41
Optogenetic Microglial Deactivation via Engineered Inhibitor
Score: 0.38
TREM2-Dependent Astrocyte-Microglia Cross-talk in Neurodegen
Score: 0.64
Show 25 more
Related Analyses (30)
TREM2 agonism vs antagonism in DAM microglia
neurodegeneration · failed
TREM2 agonism vs antagonism in DAM microglia
neurodegeneration · archived
Neuroinflammation and microglial priming in early Alzheimer'
neurodegeneration · archived
TREM2 Therapeutic Strategy Post-INVOKE-2
neurodegeneration · archived
Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived
APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived
Senolytic therapy for age-related neurodegeneration
neurodegeneration · archived
Neuroinflammation resolution mechanisms and pro-resolving me
neurodegeneration · archived
What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived
Sleep disruption as cause and consequence of neurodegenerati
neurodegeneration · archived
Synaptic pruning by microglia in early AD
neurodegeneration · archived
Tau propagation mechanisms and therapeutic interception poin
neurodegeneration · archived
SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas
neurodegeneration · completed
Microglia-astrocyte crosstalk amplification loops in neurode
neurodegeneration · archived
What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · completed
Protein aggregation cross-seeding across neurodegenerative d
neurodegeneration · archived
Mechanistic role of APOE in neurodegeneration
neurodegeneration · archived
Is disrupted sleep a cause or consequence of neurodegenerati
neurodegeneration · failed
Is disrupted sleep a cause or consequence of neurodegenerati
neurodegeneration · failed
Immune atlas neuroinflammation analysis in neurodegeneration
Neuroinflammation · archived
Microglial subtypes in neurodegeneration — friend vs foe
neuroscience · failed
Cell type vulnerability in Alzheimer's Disease (SEA-AD data)
neurodegeneration · failed
Cell type vulnerability in Alzheimer's Disease (SEA-AD data
neurodegeneration · archived
TREM2 Therapeutic Strategy Post-INVOKE-2
neurodegeneration · completed
GBA-Synuclein Loop Therapeutics for PD
neurodegeneration · completed
Gut-Brain Axis Therapeutics for AD
neurodegeneration · completed
Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · completed
Microglia-astrocyte crosstalk amplification loops in neurode
neurodegeneration · completed
Senolytic therapy for age-related neurodegeneration
neurodegeneration · completed
Synaptic pruning by microglia in early AD
neurodegeneration · completed
Show 25 more
Related Experiments (10)
Microglial Aging and Immune Memory in Neurodegeneration — Tr
validation · proposed · Score: 0.40
Longitudinal TLR2 reporter gene study in α-synuclein mice
validation · proposed · Score: 0.90
Dexamethasone treatment study in α-synuclein mice
validation · proposed · Score: 0.85
TLR expression in α-synuclein overexpressing mice
validation · proposed · Score: 0.80
AD Amyloid-Resilient Phenotype Study — Why Some amyloid-Posi
clinical · proposed · Score: 0.40
AD Combination Therapy Trial: Anti-Aβ + Anti-Tau
clinical · proposed · Score: 0.40
Sex Differences in Alzheimer's Disease — mechanisms and ther
clinical · proposed · Score: 0.40
Microglial TREM2 Agonist In Vivo Efficacy
validation · proposed · Score: 0.40
TREM2 Agonist Therapy for Parkinson's Disease — Experimental
validation · proposed · Score: 0.40
TREM2 Function in Alzheimer's Disease — From Risk Variant to
validation · proposed · Score: 0.40
Show 5 more
Knowledge Graph (12 edges)
DISEASE-ASSOCIATED MICROGLIA
associated_with
Als
DISEASE-ASSOCIATED MICROGLIA
associated_with
Aging
DISEASE-ASSOCIATED MICROGLIA
activates
Ms
DISEASE-ASSOCIATED MICROGLIA
activates
Tumor
DISEASE-ASSOCIATED MICROGLIA
activates
Phagocytosis
DISEASE-ASSOCIATED MICROGLIA
expressed_in
BRAIN INFLAMMATION
DISEASE-ASSOCIATED MICROGLIA
expressed_in
Inflammation
DISEASE-ASSOCIATED MICROGLIA
expressed_in
Alzheimer
DISEASE-ASSOCIATED MICROGLIA
expressed_in
Aging
DISEASE-ASSOCIATED MICROGLIA
expressed_in
Tauopathy